Related Experiment Video

Updated: Aug 7, 2026

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
05:12

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model

Published on: September 4, 2017

Molecular genetics of familial cerebral cavernous malformations

Shervin R Dashti1, Alan Hoffer, Yin C Hu

  • 1Department of Neurosurgery, University Hospitals of Cleveland, Case School of Medicine, Cleveland, Ohio 44106, USA.

Neurosurgical Focus
|July 25, 2006
PubMed

Insights

Familial cerebral cavernous malformations (CMs) are linked to genetic mutations at three loci (CCM1, CCM2, CCM3). Understanding these molecular events is crucial for diagnosing and potentially treating this inherited neurovascular condition.

Area of Science:

  • Neuroscience
  • Genetics
  • Vascular Biology

Background:

  • Cerebral cavernous malformations (CMs) are vascular lesions in the brain.
  • They can be sporadic or inherited in an autosomal dominant pattern.
  • Familial forms are more prevalent in Hispanic populations.

Purpose of the Study:

  • To summarize the current understanding of molecular events in familial cerebral cavernous malformations.
  • To highlight the genetic loci associated with inherited CMs.

Main Methods:

  • Review of existing literature on familial CMs.
  • Analysis of genetic loci (CCM1, CCM2, CCM3) and their associated mutations.

Main Results:

  • Familial CMs are attributed to mutations at three distinct genetic loci: CCM1 (7q21.2), CCM2 (7p15-p13), and CCM3 (3q25.2-q27).
  • No significant differences in pathology or presentation exist between sporadic and familial CMs.

Conclusions:

  • Genetic mutations in CCM1, CCM2, or CCM3 are the underlying cause of familial cerebral cavernous malformations.
  • Further research into these molecular pathways is essential for advancing treatment strategies.

More Related Videos

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Related Concept Videos

Genetic Lingo01:11

Genetic Lingo

Overview
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mutations01:39

Mutations

Overview
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...